ATP Assays Market growth forecasted to transform from USD 0.3 billion in 2023 to USD 0.5 billion by 2028, driven by a CAGR of 7.8%. The expansion of this market is primarily propelled by the shift from culture-based tests to rapid tests, rising demand for cell-based assays in research, and the rising demand for ATP assays in pharmaceutical companies. However, lack of ability to differentiate between extracellular and intracellular ATP are factors restraining the growth of this market.

Download an Illustrative overview

ATP Assays Industry Dynamics:

Drivers:

1. Increasing food safety concerns

Restraints:

1. High cost of instruments

Opportunities:

1. Technological enhancements in ATP assay probes

Challenges:

1. Survival of small players and new entrants

The consumables & accessories segment is accounted for largest share of the industry during the forecast period

On the basis of product, The ATP assays market comprises consumables & accessories as well as instruments, with the consumables & accessories segment holding a significant portion. This dominance can be attributed to the the growing demand for tumor testing and cell proliferation (specifically in cancer) driven by an upsurge in chronic diseases, and the frequent procurement of consumables by pharmaceutical and biotechnology firms.

The contamination testing segment accounted for the largest share of the market during the forecast period.

On the basis of application, The ATP assays market is bifurcated into contamination testing, disease testing, and drug delivery & development segments. The significant portion of the contamination testing segment is due to various factors such as the surge in drug discovery activities following the COVID-19 pandemic, and the necessity for cleaning and disinfecting environmental surfaces in hospitals.

The pharmaceutical & biotechnology segment accounted for the largest share of the market in 2022

On the basis of end users, The ATP assays market is categorized into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutes. The dominance of this segment can be attributed to several key factors. These include the presence of a large number of pharmaceutical players who are making substantial investments in this market, the growing regulatory approvals for cell culture-based vaccines that necessitate the use of ATP assays in contamination testing, the expansion of commercial activities by various pharmaceutical companies, the rising demand for cell and gene therapies to address chronic diseases, and significant research and development efforts in the pharmaceutical & biopharmaceutical sector.

APAC to witness the highest growth during the forecast period.

In 2022, North America accounted for the largest share the ATP assays market, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. The large share of North America can be attributed to the availability of government and private funding for life science research, growing penetration of CROs, comprehensive drug development regulations, and the presence of major players in the ATP assays market in this region.

Request Sample Pages

Key Market Players:

The prominent players in this market are Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), Neogen Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest Inc. (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech, LLC (US), Cayman Chemical (US), and Cell Signaling Technology,Inc. (US).

Recent Developments:

• In January 2022, Agilent Technologies launched Seahorse XF Pro Analyzer, enabling operators at any skill level to access the most advanced cellular metabolism analysis technology for understanding cellular fate, fitness, and function.
• In May 2021, Neogen Corporation launched AccuPoint Advanced NG. It remains the only sanitation monitoring system in the market to utilize a flat tip sampler for maximized recovery of ATP and feature RFID technology for streamlined testing processes.
• In October 2021, Abcam has doubled the footprint of its immunoassay kit R&D and manufacturing facility in Eugene, Oregon. This enhanced capacity is another component of Abcam’s growth journey in the US and will further enable its commitment to support the research and biopharma sector globally.
• In May 2020, Thermo Fisher launched the Orbitrap 240 Mass Spectrometer. It is designed to give proteomics, metabolomics, and biopharmaceutical characterization to small molecules, which aid in research and high-throughput analyses. The new system helps drive discovery and identification with increased accuracy for confident scale-up along with operational simplicity and speed.

Get 10% Free Customization on this Report

ATP Assays Market Advantages:

• Rapid and Real-time Assessment: ATP assays provide rapid and real-time measurements of cellular energy levels. They offer a quick and efficient way to monitor the dynamic changes in ATP content, allowing for immediate assessment of cellular energy status. This is particularly valuable in time-sensitive applications, such as drug discovery, where the prompt evaluation of compound effects on energy metabolism is crucial.
• Sensitivity and Accuracy: ATP assays have become increasingly sensitive, enabling the detection of low levels of ATP. This high sensitivity allows for the precise measurement of ATP concentrations, even in small sample volumes or low-energy states. The accurate quantification of ATP levels ensures reliable and reproducible results, contributing to the overall quality of research, diagnostics, and quality control processes.
• Versatility and Application Diversity: The ATP assays market caters to a wide range of applications across various industries. It finds utility in pharmaceutical and biotechnology research for assessing compound effects on cellular energy metabolism, as well as in environmental monitoring, food safety, and clinical diagnostics for evaluating microbial contamination and cell viability. The versatility of ATP assays makes them adaptable to different sample types and assay formats, enhancing their relevance in diverse settings.
• High Throughput and Automation: With advancements in assay technologies and automation systems, ATP assays can be easily scaled up to handle high sample volumes and enable high-throughput screening. This capability is particularly advantageous in industrial settings, such as drug discovery and quality control, where large-scale sample analysis is required. High throughput and automation increase efficiency, reduce labor costs, and accelerate decision-making processes.
• Non-destructive and Label-free Assays: ATP assays can be non-destructive and label-free, allowing for repeated measurements on the same sample or cell population. This non-destructive nature minimizes sample consumption and preserves the integrity of the biological material, making ATP assays suitable for longitudinal studies and kinetic analyses.
• Regulatory Compliance and Standardization: The ATP assays market is supported by established standards and regulatory guidelines, ensuring consistency and reliability in results. Standardized assay protocols and quality control measures contribute to the reproducibility and comparability of ATP measurements across different laboratories and industries.
• Technological Advancements and Innovation: The ATP assays market continues to benefit from technological advancements and innovations. Ongoing research and development efforts aim to enhance assay sensitivity, expand detection capabilities, and develop novel assay formats. These advancements fuel continuous improvement, open new applications, and drive the market forward.

Content Source:

https://www.prnewswire.com/news-releases/atp-assays-market-worth-0-5-billion–marketsandmarkets-301865507.html

https://www.marketsandmarkets.com/Market-Reports/atp-assay-market-223438780.html

https://www.marketsandmarkets.com/PressReleases/atp-assay.asp